Crosspoint Capital Strategies’s Medtronic MDT Stock Holding History

Crosspoint Capital Strategies’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,754	Closed	-$344K	–	533
2015 Q4	$344K	Buy	4,754 +4,554	+2,277%	+$343K	0.09%	178
2015 Q3	$13K	Hold	200	–	–	0.02%	381
2015 Q2	$15K	Sell	200 -1,000	-83%	-$76.4K	﹤0.01%	452
2015 Q1	$94K	Sell	1,200 -3,554	-75%	-$269K	0.05%	211
2014 Q4	$344K	Buy	4,754 +2,994	+170%	+$208K	0.12%	141
2014 Q3	$109K	Buy	1,760 +1,300	+283%	+$82.7K	0.08%	149
2014 Q2	$29K	Hold	460	–	–	0.01%	293
2014 Q1	$28K	Hold	460	–	–	0.01%	328
2013 Q4	$27K	Buy	+460	New	+$26.1K	0.01%	315

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Crosspoint Capital Strategies's MDT Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Medtronic (MDT) in Q1 2016, closing a stake of 4,754 shares — an estimated $344K sold.

Crosspoint Capital Strategies first reported a position in MDT in Q4 2013 and held it in 9 quarters. The position peaked at $344K in Q4 2015. 1,240 funds tracked by Wall St. Rank hold MDT as of Q1 2016.

Crosspoint Capital Strategies reported no remaining Medtronic position as of Q1 2016 after selling out during the quarter.
Crosspoint Capital Strategies sold 4,754 Medtronic shares in Q1 2016, an estimated $344K.
Crosspoint Capital Strategies first reported a position in Medtronic in Q4 2013 and held it in 9 quarters.
Crosspoint Capital Strategies's Medtronic position peaked at $344K in Q4 2015.
1,240 funds tracked by Wall St. Rank held Medtronic as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.